Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125721661 | 12572166 | 1 | I | 20160714 | 20160719 | 20160719 | EXP | US-PFIZER INC-2016347777 | PFIZER | 58.00 | YR | M | Y | 82.00000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125721661 | 12572166 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | 20 MG OR 50 MG | 20895 | FILM-COATED TABLET | ||||||||||
| 125721661 | 12572166 | 2 | I | ATENOLOL. | ATENOLOL | 1 | 20 MG, 1X/DAY | 73676 | 20 | MG | TABLET | QD | |||||||
| 125721661 | 12572166 | 3 | I | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125721661 | 12572166 | 2 | Blood pressure measurement |
| 125721661 | 12572166 | 3 | Blood pressure measurement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125721661 | 12572166 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125721661 | 12572166 | Cardiac failure | |
| 125721661 | 12572166 | Drug interaction | |
| 125721661 | 12572166 | Flushing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125721661 | 12572166 | 1 | 2014 | 0 |